These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4102575)

  • 1. Determination of drug resistance of Mycobacterium tuberculosis cultures.
    Montalbine V; Collins FM
    Appl Microbiol; 1971 Apr; 21(4):732-8. PubMed ID: 4102575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the Steenken minimal inhibitory concentration and the Canetti proportion methods for determining levels of drug resistance in cultures of Mycobacterium tuberculosis.
    Collins FM; Mackaness GB; Montalbine V; Smith MM
    Am Rev Respir Dis; 1968 Aug; 98(2):189-200. PubMed ID: 4174476
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug resistance in M. tuberculosis cultures determined by the Steenken MIC and Canetti proportion tests.
    Montalbine V; Collins FM; Doster B
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):78-80. PubMed ID: 4985844
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of drug resistance of M. tuberculosis strains using three different culture media.
    Montalbine V; Collins FM
    Int Z Klin Pharmakol Ther Toxikol; 1971 Feb; 4(2):260-2. PubMed ID: 4101361
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiometric and conventional drug susceptibility testing of Mycobacterium tuberculosis.
    Hoel T; Eng J
    APMIS; 1991 Nov; 99(11):977-80. PubMed ID: 1958354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mixtures of atabrine and antibacterial agents on the emergence of resistant strains of Mycobacterium tuberculosis.
    Warren GH; Gregory FJ; Healy EM; Flint SF
    Nature; 1967 Jul; 215(5100):526-7. PubMed ID: 4168326
    [No Abstract]   [Full Text] [Related]  

  • 7. [Primary resistance to INH, PAS and STM. Significance of individual mycobacterial strains for newly diagnosed cases of pulmonary tuberculosis in the middle Bohemia region in 1967 and 1972 (author's transl)].
    Víznerová A
    Cas Lek Cesk; 1974 Nov; 113(46):1419-22. PubMed ID: 4216401
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of antituberculosis chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli. II. Antituberculosis activity of INH and SM in vitro after exposure to PAS.
    Maekawa N; Nakanishi ; Kawai M; Ikeda N; Nakai H
    Kekkaku; 1971 Aug; 46(8):293-4. PubMed ID: 4998861
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs.
    Coban AY; Cihan CC; Bilgin K; Uzun M; Akgunes A; Cetinkaya E; Durupinar B
    Int J Tuberc Lung Dis; 2006 Apr; 10(4):450-3. PubMed ID: 16602412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tuberculosis by microcultivation on slides in blood medium].
    Smirnov VD
    Antibiotiki; 1971; 16(8):738-40. PubMed ID: 5003152
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H
    Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
    [No Abstract]   [Full Text] [Related]  

  • 12. [The clinical significance of the critical drug resistance concentration of SM,INH and PAS].
    Baba H; Azuma Y
    Kekkaku; 1972 Oct; 47(10):353-60. PubMed ID: 4658707
    [No Abstract]   [Full Text] [Related]  

  • 13. Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods.
    Siddiqi SH; Hawkins JE; Laszlo A
    J Clin Microbiol; 1985 Dec; 22(6):919-23. PubMed ID: 3934209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Mycobacterium tuberculosis in Africa. Vulnerable and invulnerable types of drug resistance.
    Zykov MP; Donets JI; Poti SJ
    Am Rev Respir Dis; 1972 May; 105(5):715-35. PubMed ID: 4112019
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycobacterium resistance to antimycobacterial reagent.
    Aghandous R; Zouhdi M; Zizi M; Errami M; Idrissi L
    Therapie; 1999; 54(5):623-5. PubMed ID: 10667100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian survey to determine the rate of drug resistance to isoniazid, PAS and streptomycin in newly detected untreated tuberculosis patients and retreatment cases.
    Hershfield ES; Eidus L; Helbecque DM
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):387-93. PubMed ID: 115802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new disc technique for drug sensitivity test of tubercle bacilli.
    Kudoh S; Kudoh T; Yoshikawa S
    Acta Tuberc Pneumol Scand; 1965; 46(3):207-19. PubMed ID: 4956376
    [No Abstract]   [Full Text] [Related]  

  • 18. Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China.
    Li G; Zhang J; Jiang Y; Zhao LL; Liu H; Li M; Zhao X; Wan K
    J Glob Antimicrob Resist; 2020 Mar; 20():275-281. PubMed ID: 31425771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance and speed of growth of M. tuberculosis. I. Growth on drug-free medium.
    Zykov MP; Donets JI
    Jpn J Tuberc Chest Dis; 1971 Jul; 17(1):35-9. PubMed ID: 4113511
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutational studies of the drug-resistance of M. tuberculosis with special reference to p-aminosalicylic acid, ethambutol, isoniazid and rifampicin.
    Alberghina M; Palermo F
    Boll Ist Sieroter Milan; 1975; 54(6):437-44. PubMed ID: 816363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.